Suppression of oxidized LDL-induced PDGF receptor β activation by Ginkgo Biloba extract reduces MMP-1 production in coronary smooth muscle cells

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 5, 2007, Pages 219-225

  Akiba, Satoshi ^a   Yamaguchi, Hidenori ^a   Kumazawa, Satomi ^a   Oka, Mayuko ^a   Sato, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Ginkgo Biloba extracts; Metalloproteinase 1; Oxidized low density lipoprotein; Smooth muscle cells

Indexed keywords

4 HYDROXYNONENAL; 4-HYDROXY-2-NONENAL; ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CORONARY BLOOD VESSEL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GINKGO BILOBA; HUMAN; IMMUNOPRECIPITATION; METABOLISM; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ALDEHYDES; BLOTTING, WESTERN; CELLS, CULTURED; CORONARY VESSELS; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GINKGO BILOBA; HUMANS; IMMUNOPRECIPITATION; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 1; MYOCYTES, SMOOTH MUSCLE; PLANT EXTRACTS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 38449111487     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E516     Document Type: Article

References (40)

1. Falk E, Shah PK, and Fuster V: Coronary plaque disruption. Circulation, 1995; 92:657-671
2. Galis Z and Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res, 2002; 90:251-262
3. Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, and Dacmen MJ: The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol, 2003; 200:516-525
4. Katsuda S and Kaji T: Atherosclerosis and extracellular matrix. J Atheroscler Thromb, 2003; 10:267-274
5. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res, 2003; 92:827-839
6. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, and Clowes; AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation, 1995; 92:1393-1398
7. Major TC, Liang L, Lu X, Rosebury W, and Bocan TMA: Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Bioll 2002; 22:1200-1207
8. Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, and Libby P: Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation, 1999; 99:2503-2509
9. Herman MV, Sukhova GK, Libby P, Gerdes N, Tang N, Horton DB, Kilbride M, Breitbart RE, Chun M, and Schönbeck U: Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: A nove collagenolytic pathway suggested by transcriptional profiling. Circulation, 2001; 104:1899-1904
10. Kuzuya M and Iguchi A: Role of matrix metalloproteinase in vascular remodeling. J Atheroscler Thromb, 2003; 10:275-282
11. Watari M, Watari H, DiSanto ME, Chacko S, Shi GP, and Strauss JF III: Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol, 1999; 154:1755-1762
12. Chase AJ, Bond M, Crook MF, and Newby AC: Role of nuclear factor-κB activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol, 2002; 22:765-771
13. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, and Park JE: Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Atterioscler Thromb Vasc.Biol, 2001; 21:2004-2010
14. Gerdes N, Sukhova GK Libby P, Reynolds RS, Young JL, and Schönbeck U: Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for atherogenesis. J Exp Med, 2002; 195:245-257
15. Akiba S, Kumazawa S, Yamaguchi H, Hontani N, Matsumoto T, Ikeda T, Oka M, and Sato T: Acceleration of matrix metalloproteinase-1 production and activation of platelet-derived growth factor receptor β in human coronary smooth muscle cells by oxidized LDL and 4-hydroxynoncnal. Biochim Biophys Acta, 2006; 1763:797-804
16. Lusis AJ: Atherosclerosis. Nature, 2000; 407:233-241
17. de Winther MPJ and Hofker MH: Scavenging new insights into atherogenesis. J Clin Invest, 2000; 105:1039-1041
18. Pincemail J, Dupuis M, Nasr C, Hans P, Haag-Berrurier M, Anton R, and Deby C: Superoxide anion scavenging effect and superoxide dismutase activity of Ginkgo biloba extract. Experientia, 1989; 45:708-712
19. Maitra I, Marcocci L, Droy-Lefaix MT, and Packer L: Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol, 1995; 49:1649-1655
20. Marcocci L, Maguire JJ, Droy-Lefaix MT, and Packer L: The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun, 1994; 201:748-755
21. Chen JW, Chen YH, Lin FY, Chen YL, and Lin SJ: Ginkgo biloba extract inhibits tumor necrosis factor-α-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endodielial cells. Arterioscler Thromb Vasc Biol, 2003; 23:1559-1566
22. Yan LJ, Droy-Lefaix MT, and Packer L: Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Commun, 1995; 212:360-366
23. Lamant V, Mauco G, Braquet P, Chap H, and Douste-Blazy L: Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol, 1987; 36:2749-2752
24. Shen J, Wang J, Zhao B, Hou J, Gao T, and Xin W: Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo. Biochim. Biophys Acta, 1998; 1406:228-236
25. Zhang WR, Hayashi T, Kitagawa H, Sasaki C, Sakai K, Warita H, Wang JM, Shiro Y, Uchida M, and Abe K: Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res, 2000; 22:517-521
26. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Drieu K, and Fiskum G: Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res, 2001; 922:282-292
27. DeFeudis FV and Drieu K: Ginkgo biloba extract (EGb 761) and CNS fiinctions: basic studies and clinical applications. Curr Drug Targets, 2000; 1:25-58
28. Yoshikawa T, Naito Y, and Kondo M: Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal, 1999; 1:469-480
29. Lin SJ, Yang TH, Chen YH, Chen JW, Kwok CF, Shiao MS, and Chen YL: Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1β expression after balloon injury in cholesterol-fed rabbits in vivo. J Cell Biochem, 2002; 85:572-582
30. Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, Huang CJ, Kandaswami C, Middleton E Jr., and Lee MT: Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol, 1999; 128:999-1010
31. Kim SY, Jin YR, Lim Y, Kim JH, Cho MR, Hong JT, Yoo HS, and Yun YP: Inhibition of PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth-muscle cells by kaempferol. Planta Med, 2005; 71:599-603
32. Akiba S, Yoneda. Y, Ohno S, Nemoto M, and Sato T: Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification. J Lipid Res, 2003; 44:1676-1685
33. 2 and PDGF in mesangial cells. Am J Physiol, 2002; 282:F485-F491
34. Sun Y, Wenger L, Brinckerhoff CE, Misra RR, and Cheung HS: Basic calcium phosphate crystals induce matrix metalloproteinase-I through the Ras/ mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase. 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3. J Biol Chem, 2002; 277:1544-1552
35. Luo H and Reidy MA: Activation of big mitogen-activated protein kinase-1 regulates smooth muscle cell replication. Arterioscler Thromb Vasc Biol, 2002; 22:394-399
36. Conway AM, Rakhit S, Pyne S, and Pyne NJ: Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: Role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Biochem J, 1999; 337:171-177
37. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, and Sobue K: Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol, 1999; 145:727-740
38. Escargueil-Blanc I, Salvayre R, Vacaresse N, Jürgens G, Darblade B, Arnal JF, Parthasarathy S, and Nègre-Salvayre A: Mildly oxidized LDL induces activation of platelet-derived growth factor β-receptor pathway. Circulation, 2001; 104:1814-1821
39. Vindis C, Escargueil-Blanc I, Elbaz M, Marcheix B, Grazide MH, Uchida K, Salvayre R, and Nègre-Salvayre A: Desensitization of platelet-derived growth factor receptor-β by oxidized lipids in vascular cells and atheroslerotic lesions: prevention by aldehyde scavengers. Circ Res, 2006; 98:785-792
40. Akiba S, Chiba M, Mukaida Y, Tamura A, and Sato T: The leaf extract of Ginkgo Biloba L. suppresses oxidized LDL-stimulated fibronectin production through an anti-oxidant action in rat mesangial cells. Br J Pharmacol, 2004; 142:419-424